Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | TTR | P02766 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9135914 | 0.91 | FFAR1 (0.50) | ESR1KDM4EALDH1A1KMT2ACYP19A1 | |
| SCHEMBL19612707 | 0.84 | ACHE (0.58) | ESR1ESR2KDM4EALDH1A1LMNA | |
| SCHEMBL9440306 | 0.82 | CA1 (0.48) | ALDH1A1TDP1HDAC2HDAC8CA2 | |
| SCHEMBL1154480 | 0.82 | PLAAT3 (0.53) | KDM4EALDH1A1KMT2ACYP2C19MEN1 | |
| SCHEMBL8108885 | 0.81 | ESR1 (0.62) | ESR1ESR2KDM4EALDH1A1KMT2A | |
| SCHEMBL1446802 | 0.80 | FFAR1 (0.55) | ALDH1A1TDP1LMNACYP1A2MAPT | |
| SCHEMBL30799017 | 0.80 | ALDH1A1 (0.48) | ALDH1A1HDAC2HDAC8LMNATSHR | |
| SCHEMBL27505250 | 0.80 | TPSAB1 (0.47) | KDM4ECA2 | |
| SCHEMBL594085 | 0.80 | FFAR1 (0.50) | KMT2AMEN1POLBTAAR1 | |
| SCHEMBL1154606 | 0.80 | FFAR1 (0.55) | LMNAGAASLC5A1HPGDSLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117902994-B | Preparation method of 2- (3- (4-hydroxyphenyl) propionylamino) benzoic acid | 中山海泓药业有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-118290291-A | Synthesis method of dihydro oat alkaloid D | 微著生物科技(东营)有限责任公司 | 2024-07-05 | — | — | CN | claimed |
| CN-117902994-A | Preparation method of 2- (3- (4-hydroxyphenyl) propionylamino) benzoic acid | 中山海泓药业有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-110627832-A | Preparation method for synthesizing tenofovir alafenamide by oxidation method | 江西农业大学 | 2019-12-31 | — | — | CN | claimed |
| CN-117902994-B | Preparation method of 2- (3- (4-hydroxyphenyl) propionylamino) benzoic acid | 中山海泓药业有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-118290291-A | Synthesis method of dihydro oat alkaloid D | 微著生物科技(东营)有限责任公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-117902994-A | Preparation method of 2- (3- (4-hydroxyphenyl) propionylamino) benzoic acid | 中山海泓药业有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-117902994-A | Preparation method of 2- (3- (4-hydroxyphenyl) propionylamino) benzoic acid | 中山海泓药业有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-117800866-A | Synthesis method and application of 2- (3- (4-hydroxyphenyl) propionylamino) benzoic acid | 信阳师范学院 | 2024-04-02 | — | — | CN | disclosed |
| CN-112939803-B | Preparation process of dihydro oat alkaloid D | 郑州轻工业大学 | 2023-07-18 | — | — | CN | disclosed |
| CN-114478296-A | Preparation method of dihydrooat alkaloid | 河南旭瑞新材料科技有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-109553550-B | Method for synthesizing dihydrooat alkaloid | 上海克琴科技有限公司 | 2022-02-22 | — | — | CN | disclosed |
| US-20100249078-A1 | TETRACYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE | THE SCRIPS RESEARCH INSTITUTE (US) | 2010-09-30 | — | — | US | disclosed |
| US-7727434-B2 | Membranes and methods of treating membranes | GENERAL ELECTRIC COMPANY (US) | 2010-06-01 | — | — | US | disclosed |
| EP-2152082-A1 | TETRACYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE | The Scripps Research Institute (US) | 2010-02-17 | — | — | EP | disclosed |
| WO-2008147553-A1 | TETRACYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE | THE SCRIPPS RESEARCH INSTITUTE (US) | 2008-12-04 | — | — | WO | disclosed |
| US-20070112009-A1 | 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them | LABORATOIRE THERAMEX (MC) | 2007-05-17 | — | — | US | disclosed |
| US-20070039874-A1 | Membranes and methods of treating membranes | GENERAL ELECTRIC COMPANY | 2007-02-22 | — | — | US | disclosed |
| EP-1694650-A1 | 1-N-PHENYL-AMINO-1H-IMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LABORATOIRE THERAMEX (MC) | 2006-08-30 | — | — | EP | disclosed |
| WO-2005058842-A1 | 1-N-PHENYL-AMINO-1H-IMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LABORATOIRE THERAMEX (MC) | 2005-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249078-A1 | TETRACYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE | FAAH, FAAH2, APEH | ESR1 3946/4885ESR2 2370/4885KDM4E 1417/4885 |
| US-20070112009-A1 | 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them | H1-0, H1-5, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | ESR1 2656/4885ESR2 3407/4885KDM4E 391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.